\section{Uncoating numbers for reaction models}
\label{appendix:uncoatingNumbers}

\begin{landscape}
\begin{table}[h!]
\caption[Mean values of influenza uncoating numbers]{Mean values of influenza uncoating numbers with different treatments.\\Values presented as mean (median) $\pm$ standard deviation}
\end{table}

\begin{longtable}{@{}lrrrl@{}}

\toprule
\multicolumn{1}{c}{\textbf{treatment}}&
\multicolumn{1}{c}{\textbf{experimental}}&
\multicolumn{1}{c}{\textbf{asymmetric}}&
\multicolumn{1}{c}{\textbf{symmetric}}&
\multicolumn{1}{c}{\textbf{comment}}\\
\midrule
\endhead % all the lines above this will be repeated on every page

%PanelA________________________________________________________________________________________________________________
\midrule
\multicolumn{5}{l}{\textbf{Figure \ref{figure:reactionModelPredictions}A}}\\
\midrule
\multicolumn{5}{l}{\textit{dynein binding}}\\
WT &
100 (83) $\pm$ 29 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
siRNA Dynactin2 &
55 (59) $\pm$ 13 &
70 (70) $\pm$ 2 &
66 (66) $\pm$ 2 &
dynein/10\\

\midrule
\multicolumn{5}{l}{\textit{dynein walking}}\\
WT &
100 (99) $\pm$ 9 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal \\
\makecell[l]{CiliobrevinD \\(AAA ATPase,\\dynein inhibitor)} &
63 (70) $\pm$ 15 &
54 (54) $\pm$ 0 &
58 (58) $\pm$ 2 &
\makecell[l]{dynein stops walking:\\normal, but breakage\\only depends\\on myosins}\\

\midrule
\multicolumn{5}{l}{\textit{myosin binding}}\\
WT &
100 (97) $\pm$ 22 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
siRNA Myosin9 &
97 (100) $\pm$ 7 & \NA & \NA &
\NA \\
siRNA Myosin10 &
43 (36) $\pm$ 15 &
15 (15) $\pm$ 1 &
24 (24) $\pm$ 4 &
\makecell[l]{myosin/5\\ (myosin depletion\\efficiency\\was limited)}\\

\midrule
\multicolumn{5}{l}{\textit{myosin walking}}\\
WT &
100 (104) $\pm$ 12 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5
& normal\\
\makecell[l]{ML-9 \\(myosin light chain\\kinase inhibitor)} &
39 (39) $\pm$ 6 & \NA & \NA &
myosin stops walking\\
\makecell[l]{Blebbistatin \\(myosin II inhibitor)} &
49 (49) $\pm$ 3 & \NA & \NA &
myosin stops walking \\
\midrule
%PanelB________________________________________________________________________________________________________________
\multicolumn{5}{l}{\textbf{Figure \ref{figure:reactionModelPredictions}B}}\\
\midrule
\multicolumn{5}{l}{\textit{HDAC6 DMB mutant}}\\
WT &
100 (93) $\pm$ 20 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
\makecell[l]{HDAC6 $\Delta$DMB\\MEF cell line} &
59 (65) $\pm$ 26 &
65 (65) $\pm$ 1 &
57 (57) $\pm$ 1 &
\makecell[l]{$K_{HD} \cdot$1000\\ (binding shouldn't\\happen since\\it's a deletion)}\\
\midrule
\multicolumn{5}{l}{\textit{HDAC6 KO (bypass)}}\\
WT &
100 (92) $\pm$ 21 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
\makecell[l]{HDAC6 KO\\MEF cell line} &
33 (28) $\pm$ 11 &
1 (0) $\pm$ 2 &
4 (2) $\pm$ 5 &
HDAC6/100\\

\midrule
\makecell[l]{\textit{HDAC6 KO (endosomal)}}\\
WT &
100 (100) $\pm$ 7 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
\makecell[l]{HDAC6 KO\\MEF cell line} &
22 (24) $\pm$ 4 &
1 (0) $\pm$ 2 &
4 (2) $\pm$ 5 &
HDAC6/100\\

\midrule
\makecell[l]{\textit{HDAC6 siRNA}}\\
WT &
100 (97) $\pm$ 19 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
siRNA HDAC6 &
48 (49) $\pm$ 16 &
3 (3) $\pm$ 1 &
41 (41) $\pm$ 5 &
HDAC6/10\\

\midrule
\makecell[l]{\textit{HDAC6 Znf mutant}}\\
WT &
100 (105) $\pm$ 11 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5
& normal\\
\makecell[l]{HDAC6 ZnFm\\(W1116A)\\MEF cell line} &
21 (18) $\pm$ 9 &
4 (4) $\pm$ 0 &
0 (0) $\pm$ 0
&\makecell[l]{$k_{UH} \cdot$1000\\(binding shouldn't\\happen but it's\\still observed\\in the presence\\of Cyto D)}\\
\midrule

%PanelC________________________________________________________________________________________________________________
\multicolumn{5}{l}{\textbf{Figure \ref{figure:reactionModelPredictions}C}}\\
\midrule
\makecell[l]{\textit{cytoskeleton polymerisation}}\\
WT &
100 (98) $\pm$ 7 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 & normal\\
\makecell[l]{Cytochalasin D \\ (actin\\polymerisation\\ inhibitor)} & 
17 (18) $\pm$ 4 &
33 (33) $\pm$ 1 &
21 (21) $\pm$ 2 &
actin/10\\
\makecell[l]{Nocodazole \\(tubulin\\polymerisation\\inhibitor)} &
65 (64) $\pm$ 1 &
97 (97) $\pm$ 3 &
75 (75) $\pm$ 2 &
\makecell[l]{tubulin/100\\(because of high\\concentration of\\tubulin, and in\\ microscopy experiments\\ nocadazole leads to\\ strong depolymerization)}\\
\makecell[l]{Cytochalasin D\\ \& Nocodazole} &
6 (5) $\pm$ 2 &
31 (31) $\pm$ 2 &
2 (2) $\pm$ 1 &
\makecell[l]{actin/10 and\\tubulin/100} \\

\midrule
\multicolumn{5}{l}{\textit{drug screen (endosomal)}}\\
WT &
100 (103) $\pm$ 20 &
100 (100) $\pm$ 8 &
100 (100) $\pm$ 8 &
normal\\
\makecell[l]{Cytochalasin D\\(actin\\polymerisation\\inhibitor)} &
37 (40) $\pm$ 15 &
33 (33) $\pm$ 1 &
21 (21) $\pm$ 2 &
actin/10\\
\makecell[l]{Nocodazole\\(tubulin\\polymerisation\\inhibitor)} &
56 (58) $\pm$ 15 &
97 (97) $\pm$ 3 &
75 (75) $\pm$ 2 &
tubulin/100\\
\makecell[l]{ML-9\\(myosin light\\chain kinase\\inhibitor)}  &
22 (25) $\pm$ 5 & \NA & \NA &
\makecell[l]{myosin stops\\walking}\\
\makecell[l]{CiliobrevinD\\(AAA ATPase,\\dynein inhibitor)} &
39 (38) $\pm$ 8 &
54 (54) $\pm$ 0 &
58 (58) $\pm$ 2 &
\makecell[l]{dynein stops\\walking} \\
\makecell[l]{Importazole\\(importin beta\\inhibitor)} &
70 (66) $\pm$ 21 & \NA & \NA &
negative control\\
\makecell[l]{MG132\\(proteasome\\inhibitor)} &
87 (94) $\pm$ 12 &
71 (71) $\pm$ 3 &
69 (69) $\pm$ 6 &
Ub/10\\
\midrule

\newpage

%Figure6PanelF(PanelD)________________________________________________________________________________________________________________
\multicolumn{5}{l}{\textbf{Figure \ref{figure:M1ReactionModel}}}\\
\midrule
\multicolumn{5}{l}{\textit{M1 binding signal}}\\
H1N1 M1 &
100 (100) $\pm$ 3 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
H1N1 M1 T218A &
48 (48) $\pm$ 8  &
50 (51) $\pm$ 6 &
60 (60) $\pm$ 7 &
\makecell[l]{$K_{CH} \cdot C$.\\$C_{Asymmetric} = 12.2$,\\$C_{Symmetric} = 16.7$,\\as defined by fitting\\ capsid breakage to\\Figure 4C, D values}\\
H3N2 M1 &
31 (31) $\pm$ 6 &
50 (51) $\pm$ 6 &
60 (60) $\pm$ 7 &
$K_{CH} \cdot C$\\
H3N2 M1 A218T &
88 (88) $\pm$ 3 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\

\midrule
\multicolumn{5}{l}{\textit{Virus infectivity}}\\
pH1N1 ko/ki wt &
100 (98) $\pm$ 57 &
100 (100) $\pm$ 1 &
100 (100) $\pm$ 5 &
normal\\
\makecell[l]{pH1N1 ko/ki\\ZnF mutant} &
17 (3) $\pm$ 26 &
4 (4) $\pm$ 0 &
0 (0) $\pm$ 0 &
$K_{HU} \cdot$1000\\
H3N2 ko/ki wt &
68 (68) $\pm$ 18 &
50 (51) $\pm$ 6 &
60 (60) $\pm$ 7 &
$K_{CH} \cdot C$\\
\makecell[l]{H3N2 ko/ki\\ZnF mutant} &
45 (42) $\pm$ 18 &
0 (0) $\pm$ 0 &
0 (0) $\pm$ 0 &
$K_{CH} \cdot C$ and $K_{HU} \cdot$1000 \\
\bottomrule
\end{longtable}
%\end{table}

\end{landscape}